Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Gelderblom, Hans"'
Autor:
van de Wal D; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., den Hollander D; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands., Desar IME; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands., Oosten AW; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, The Netherlands., Reyners AKL; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Steeghs N; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Husson O; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Surgical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, The Netherlands., van der Graaf WTA; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. w.t.a.vandergraaf@erasmusmc.nl.; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, The Netherlands. w.t.a.vandergraaf@erasmusmc.nl.
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2024 Apr 10; Vol. 32 (5), pp. 279. Date of Electronic Publication: 2024 Apr 10.
Autor:
Roets E; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Ijzerman NS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Ho VKY; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands., Desar IME; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Reyners AKL; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., Grünhagen DJ; Department of Surgical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Van Etten B; University of Groningen, University Medical Center Groningen, Department of Surgical Oncology and gastrointestinal surgery, Groningen, the Netherlands., Van Houdt WJ; Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Van der Graaf WTA; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands. w.vd.graaf@nki.nl., Steeghs N; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Publikováno v:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2024 Feb 14; Vol. 63, pp. 28-34. Date of Electronic Publication: 2024 Feb 14.
Autor:
Bleckman RF; University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. r.f.bleckman@umcg.nl.; Department of Medical Oncology, University Medical Center Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands. r.f.bleckman@umcg.nl., Broekman KE; University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Department of Medical Oncology, University Medical Center Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands., Roets E; The Netherlands Cancer Institute, Amsterdam, The Netherlands., Mohammadi M; Leiden University Medical Center, Leiden, The Netherlands., Desar IME; Radboud University Medical Center, Nijmegen, The Netherlands., Gelderblom H; Leiden University Medical Center, Leiden, The Netherlands., Mathijssen RHJ; Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Steeghs N; The Netherlands Cancer Institute, Amsterdam, The Netherlands., de Graeff P; University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Department of Medical Oncology, University Medical Center Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands., Reyners AKL; University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Department of Medical Oncology, University Medical Center Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.
Publikováno v:
Drugs & aging [Drugs Aging] 2024 Feb; Vol. 41 (2), pp. 165-176. Date of Electronic Publication: 2023 Dec 20.
Autor:
Heinrich MC; Division of Hematology/Oncology, Portland VA Health Care System, Portland, OR, USA.; Department of Medicine, OHSU Knight Cancer Institute, Portland, OR, USA., Jones RL; Sarcoma Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, UK., George S; Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands., Schöffski P; Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, KU Leuven, Leuven, Belgium., von Mehren M; Department of Hematology/Oncology, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA, USA., Zalcberg JR; Department of Medical Oncology, Monash University School of Public Health and Preventive Medicine, Alfred Health, Melbourne, Victoria, Australia., Kang YK; Department of Oncology, Asan Medical Center, University of Ulsan, Seoul, Korea., Razak AA; Division of Medical Oncology, Toronto Sarcoma Program, Princess Margaret Cancer Center, Toronto, ON, Canada., Trent J; Department of Medical Oncology, Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL, USA., Attia S; Department of Medical Oncology, Mayo Clinic, Jacksonville, FL, USA., Le Cesne A; Medical Oncology Department, Gustave Roussy, Villejuif, France., Siontis BL; Department of Medical Oncology, Mayo Clinic, Rochester, MN, USA., Goldstein D; Department of Medical Oncology, Prince of Wales Hospital, Randwick, New South Wales, Australia., Boye K; Department of Tumor Biology, Oslo University Hospital, Oslo, Norway., Sanchez C; Department of Hematology-Oncology, Centro de Cáncer, Hospital Clínico Pontificia Universidad Católica de Chile, Santiago, Chile., Steeghs N; Department of Medical Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands., Rutkowski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warszawa, Poland., Druta M; Sarcoma Program, Moffitt Cancer Center, Tampa, FL, USA., Serrano C; Sarcoma Translational Research Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Somaiah N; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chi P; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Reichmann W; Biometrics, Deciphera Pharmaceuticals, LLC, Waltham, MA, USA., Sprott K; Biometrics, Deciphera Pharmaceuticals, LLC, Waltham, MA, USA.; Translational Medicine, Deciphera Pharmaceuticals, LLC, Waltham, MA, USA., Achour H; Biometrics, Deciphera Pharmaceuticals, LLC, Waltham, MA, USA.; Clinical Development, Deciphera Pharmaceuticals, LLC, Waltham, MA, USA., Sherman ML; Clinical Development, Deciphera Pharmaceuticals, LLC, Waltham, MA, USA., Ruiz-Soto R; Clinical Development, Deciphera Pharmaceuticals, LLC, Waltham, MA, USA., Blay JY; Department of Medical Oncology, Centre Léon Bérard, Lyon, France., Bauer S; Department of Medical Oncology and Sarcoma Center, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany. Sebastian.Bauer@uk-essen.de.; German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany. Sebastian.Bauer@uk-essen.de.
Publikováno v:
Nature medicine [Nat Med] 2024 Feb; Vol. 30 (2), pp. 498-506. Date of Electronic Publication: 2024 Jan 05.
Autor:
van de Wal D; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van Doorn B; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., den Hollander D; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Desar IME; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Oosten AW; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Reyners AKL; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Steeghs N; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Clinical Pharmacology, The Netherlands Cancer Institute, The Netherlands., van der Graaf WTA; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Husson O; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Surgical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, The Netherlands.
Publikováno v:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2023 Dec; Vol. 62 (12), pp. 1616-1624. Date of Electronic Publication: 2023 Nov 25.
Autor:
Gelderblom H; Leiden University Medical Center, Leiden, the Netherlands., Jones RL; Royal Marsden Hospital and Institute of Cancer Research, London, UK., Blay JY; Centre Léon Bérard and University Claude Bernard Lyon 1, Lyon, France., George S; Dana-Farber Cancer Institute, Boston, MA, USA., von Mehren M; Fox Chase Cancer Center, Philadelphia, PA, USA., Zalcberg JR; Department of Medical Oncology, Alfred Health and School of Public Health, Monash University, Melbourne, Australia., Kang YK; Asan Medical Center, University of Ulsan, Seoul, Korea., Razak AA; Princess Margaret Cancer Centre, Toronto, ON, Canada., Trent J; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA., Attia S; Mayo Clinic, Jacksonville, FL, USA., Le Cesne A; Gustave Roussy, Vellejuif, France., Siontis BL; Mayo Clinic, Rochester, MN, USA., Goldstein D; Prince of Wales Hospital and Clinical School University of New South Wales, New South Wales, Australia., Boye K; Department of Oncology, Oslo University Hospital, Oslo, Norway., Sanchez C; Department of Hematology and Oncology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile., Steeghs N; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Rutkowski P; Maria Sklodowska-Curie National Research Institute of Oncology, Warszawa, Poland., Druta M; Moffit Cancer Center, Tampa, FL, USA., Serrano C; Vall d'Hebron Institute of Oncology, Barcelona, Spain., Somaiah N; MD Anderson Cancer Center, Houston, TX, USA., Chi P; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Harrow B; Deciphera Pharmaceuticals, LLC, Waltham, MA, USA. Electronic address: brooke.harrow@deciphera.com., Becker C; Deciphera Pharmaceuticals, LLC, Waltham, MA, USA., Reichmann W; Deciphera Pharmaceuticals, LLC, Waltham, MA, USA., Sherman ML; Deciphera Pharmaceuticals, LLC, Waltham, MA, USA., Ruiz-Soto R; Deciphera Pharmaceuticals, LLC, Waltham, MA, USA., Heinrich MC; Portland VA Healthcare System and Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA., Bauer S; Department of Medical Oncology and Sarcoma Center at the West German Cancer Center, University Hospital Essen, Essen, Germany; German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Oct; Vol. 192, pp. 113245. Date of Electronic Publication: 2023 Jul 20.
Autor:
Brink P; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands., Kalisvaart GM; Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: G.M.Kalisvaart@lumc.nl., Schrage YM; Department of Surgery, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Mohammadi M; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., Ijzerman NS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Bleckman RF; Department of Medical Oncology, University Medical Centre Groningen, Groningen, the Netherlands., Wal T; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., de Geus-Oei LF; Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands; Biomedical Photonic Imaging Group, University of Twente, Enschede, the Netherlands., Hartgrink HH; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands., Grunhagen DJ; Department of Surgery, Erasmus Medical Center, Rotterdam, the Netherlands., Verhoef C; Department of Surgery, Erasmus Medical Center, Rotterdam, the Netherlands., Sleijfer S; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands., Oosten AW; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands., Been LB; Department of Surgery, University Medical Centre Groningen, Groningen, the Netherlands., van Ginkel RJ; Department of Surgery, University Medical Centre Groningen, Groningen, the Netherlands., Reyners AKL; Department of Medical Oncology, University Medical Centre Groningen, Groningen, the Netherlands., Bonenkamp HJ; Department of Surgery, Radboud University Medical Center, Nijmegen, the Netherlands., Desar IME; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., van Houdt WJ; Department of Surgery, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Steeghs N; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Fiocco M; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands; Mathematical Institute, Leiden University, Leiden, the Netherlands., van der Hage JA; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands.
Publikováno v:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2023 Sep; Vol. 49 (9), pp. 106942. Date of Electronic Publication: 2023 May 23.
Autor:
Bleckman RF; University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands. Electronic address: r.f.bleckman@umcg.nl., Roets E; The Netherlands Cancer Institute Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., IJzerman NS; The Netherlands Cancer Institute Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Erasmus MC Cancer Institute, Erasmus University Medical Center, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands., Mohammadi M; Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands., Bonenkamp HJJ; Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands., Gelderblom H; Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands., Mathijssen RHJ; Erasmus MC Cancer Institute, Erasmus University Medical Center, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands., Steeghs N; University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands., Reyners AKL; University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands., van Etten B; University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Jun; Vol. 186, pp. 113-121. Date of Electronic Publication: 2023 Mar 16.
Autor:
Mohammadi M; Department of Medical Oncology, Leiden University Medical Center, Leiden, 2300 RC, The Netherlands. m.mohammadi@lumc.nl., IJzerman NS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Hollander DD; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Bleckman RF; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Oosten AW; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Desar IME; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Reyners AKL; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Steeghs N; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
Publikováno v:
Targeted oncology [Target Oncol] 2023 May; Vol. 18 (3), pp. 415-423. Date of Electronic Publication: 2023 Apr 20.
Autor:
Dirkson A; Leiden Institute of Advanced Computer Science, Leiden University, Niels Bohrweg 1, 2333 CA Leiden, Netherlands. Electronic address: a.r.dirkson@liacs.leidenuniv.nl., Verberne S; Leiden Institute of Advanced Computer Science, Leiden University, Niels Bohrweg 1, 2333 CA Leiden, Netherlands. Electronic address: s.verberne@liacs.leidenuniv.nl., van Oortmerssen G; Leiden Institute of Advanced Computer Science, Leiden University, Niels Bohrweg 1, 2333 CA Leiden, Netherlands. Electronic address: g.van.oortmerssen@liacs.leidenuniv.nl., Gelderblom H; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA Leiden, Netherlands. Electronic address: A.J.Gelderblom@lumc.nl., Kraaij W; Leiden Institute of Advanced Computer Science, Leiden University, Niels Bohrweg 1, 2333 CA Leiden, Netherlands. Electronic address: w.kraaij@liacs.leidenuniv.nl.
Publikováno v:
Journal of biomedical informatics [J Biomed Inform] 2023 Mar; Vol. 139, pp. 104228. Date of Electronic Publication: 2022 Oct 26.